华恒生物(688639.SH)拟发行H股股票并在香港联交所主板挂牌上市

Core Viewpoint - Company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance global development strategy and brand influence [1] Group 1 - The board of directors has approved the proposal for issuing H-shares [1] - The initiative aims to leverage international capital market resources and mechanisms [1] - The goal is to optimize capital structure and broaden financing channels [1] Group 2 - The move is intended to strengthen the company's governance and overall capabilities [1] - The company seeks to consolidate its leading position in the industry [1]